English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 854143      Online Users : 1504
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Periodical Articles [100/101]

    Collection Statistics

    Item counts issued in 3 years:2(8.33%)
    Items With Fulltext:19(79.17%)

    Download counts of the item
    Download times greater than 0:19(100.00%)
    Download times greater than 100:19(100.00%)
    Total Bitstream Download Counts:10496(16.32%)

    Last Update: 2024-11-28 19:02


    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 1-10 of 24. (3 Page(s) Totally)
    1 2 3 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2022-07 Potential roles of gut microbiome in patients with hepatocellular carcinoma treated with immune checkpoint inhibitors Annals of Oncology. 2022 Jul;33(Suppl. 6):S484.
    2022-02-01 A prospective phase II study of biweekly S-1, leucovorin and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma Journal of Clinical Oncology. 2022 Feb 01;40(4, Suppl.):550.
    2021-07 Atezolizumab plus bevacizumab for patients with advanced hepatocellular carcinoma and chronic hepatitis B virus infection with high viral load Annals of Oncology. 2021 Jul;32(Suppl. 3):S141-S142.
    2021-05 A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy Journal of Clinical Oncology. 2021 May;39(15, Suppl.):Abstract number 6025.
    2020-02 Interim overall survival analysis of APHINITY (BIG 4-11): A randomized multicenter, double-blind, placebo-controlled trial comparing chemotherapy plus trastuzumab plus pertuzumab versus chemotherapy plus trastuzumab plus placebo as adjuvant therapy in pat Cancer Research. 2020 Feb;80(4, Suppl.):Meeting Abstract GS1-04.
    2019-05 An open label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy and safety of TLC388 as second-line treatment in subjects with poorly differentiated neuroendocrine carcinomas (TCOGT1Z14) Journal of Clinical Oncology. 2019 May;37(15, Suppl. S):Abstract number 4101.
    2018-01 The association between lifestyle factors and oral potentially malignant disorders in Taiwan Cancer Science. 2018 Jan;109(Suppl. 1):325.
    2017-07-31 The treatment patterns of non-metastatic prostate cancer in an Asian country International Journal of Urology. 2017 Jul 31;24(Suppl. S1):98.
    2017-05 Prevalence and estimated trend in chemotherapy use near death from population-based studies on cancer patients: A systematic review and meta-analysis Journal of Clinical Oncology. 2017 May;35(Suppl. 15):Meeting Abstract 6590.
    2017 Prediction of hepatitis B virus reactivation in lymphoma patients with resolved hepatitis B virus infection who received rituximab-containing chemotherapy: The roles of antiHBc/antiHBs quantification Journal of Hepatology. 2017;66(1, Suppl.):S259.

    Showing items 1-10 of 24. (3 Page(s) Totally)
    1 2 3 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback